chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"Pfizer-BioNTech COVID 19 Vaccine EUA" Severe pain at point of injection within 3 hours of shot; next day, around 24 hours after show, aches, tired, chills, fever, severe headache, nausea.  had for 24 hours.  Then, 36 hours later had headache. Patient did have COVID July of 2020.  Was sick for 18 days with fever and severe body aches, headache, fever.  Lost consciousness at one point and went to hospital.  Released and told to come back if shortness of breath occurred or symptoms worsened.
Swelling, redness, very hot, doubled in size on the evening of 04/06/09. Mother gave Benadryl and the next morning pt. woke up screaming of pain. Mother took Pt to the ER on the morning of 04/07/09.
Breakthrough menstrual bleeding (came on 3 hours after the 2nd dose.Onset migraine with vomiting (4 days after 2nd dose); Breakthrough menstrual bleeding (came on 3 hours after the 2nd dose.Onset migraine with vomiting (4 days after 2nd dose); Breakthrough menstrual bleeding (came on 3 hours after the 2nd dose.Onset migraine with vomiting (4 days after 2nd dose); This is a spontaneous report from a contactable consumer (patient). A 38-years-old non pregnant adult female patient received second dose of bnt162b2 (BNT162B2, solution for injection, (Batch/Lot Number: EM9810) administered in left arm via an unknown route  (at the age of 38 years old) on 05Mar2021 at 12:00pm as dose 2, single for covid-19 immunisation.  Medical history included known allergies to Penicillin, Sulfa, Strawberries, Malt. The patient previously received first dose of bnt162b2 (BNT162B2, solution for injection, (Batch/Lot Number: EL9269) administered in left arm via an unknown route in Feb2021 at 11:00 am as dose 1, single for covid-19 immunization and experienced no adverse event. There was no other medical history. No other vaccine was administered in four weeks. Concomitant medications in two weeks included Desogestrel, Ethinylestradiol (ISIBLOOM) Cetirizine hydrochloride (ZYRTEC), Colecalciferol (VITAMIN D [COLECALCIFEROL, Vitamin b complex (B COMPLEX), Vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]). prior vaccination, patient has not diagnosed with covid. Patient was not tested for covid post vaccination. On 05Mar2021 at 03:00pm, the patient had breakthrough menstrual bleeding (came on 3 hours after the 2nd dose). On 09Mar2021, the patient experienced migraine with vomiting (4 days after 2nd dose) with breakthrough menstrual bleeding (came on 3 hours after the 2nd dose. No treatment was received for the events. The outcome of all the events was reported as recovering.   No follow-up attempts are possible. No further information is expected.
Redness, swelling, soreness at upper arm from elbow to armpit, most severe at location vaccine given. Onset of local irritation started the night receiving vaccine, reported two days later. Suggested to contact prescriber and prescriber instructed to take Benadryl and apply ice.
We were under the impression we administered the Pfizer Bivalent COVID booster but we actually administered Pfizer Monovalent COVID vaccine in error. The patient was notified and given CDC guidance on how to proceed with future dosing.
pt states he had soreness all over and sores in the genitals and mouth.  Pt went to PCP on 2/22/2021.  Swab and labs showed it was a bacterial yeast infection.  He was given antibiotic and antifungal medicine.  He was referred to a urologist.  He went to Urology Clinic.  He was put on a different antibiotic and more antifungal meds.  He had multiple appts with them and still being treated today since it has become a chronic health condition since taking vaccine.  His Dx is Erosive Lichen Planus.
Extreme headache , fatigue, abdominal pain, unusual amount of blood clot in period 4/9-4/13
Temp to 101.4 6-28-16 7:00 am. No redness or tenderness at site of vaccines.
Visible reaction includes facial drooling but patient was stable. Patient was given some Benadryl and observed for 30 minutes before being asked to go home
0.25ml given as first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (0.25ml given as first dose) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (0.25ml given as first dose). On 09-Dec-2021, ACCIDENTAL UNDERDOSE (0.25ml given as first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No adverse reaction observed. No pre existing medical condition. No concomitant medication were given. No treatment information were given.
SEVERE Tachycardia lasting for a sold 30 minutes before subsiding that randomly for the next 36 hours before completely being resolved. Almost went to ER for further evaluation, would have if symptoms didn't improve at 48 hours. Called a doctor which stated to take Benadryl for possible allergic reaction which helped along with monitoring Blood Pressure, also took Ibuprofen and Tylenol to help with discomfort and inflammation.
One week, following administration of her bivalent dose, client developed intense pruritus on head,  spreading to chest, ribs, arms, armpits, and neck back. Persisted a week, treated at home with hot showers and emollience, with only  intermittent relief, self resolved.
24hrs p/vax arm became red, warm to touch;instructed to use ice-some improvement by 36hrs;
pt recvd vax & w/in 1hr post vax pt was flushed,chilled,exp a strange sensation coming up throat through chest,& had gray colored streaks around nose & mouth;sx lasted 1 hrs;19OCT94 recvd 2nd dose of vax w/no adverse effect
1/27/21 Vaccine  9:45 injection - mederma 10:09 eyelids itching - declined Benadryl 10:30 end of observation @ clinic 11:15 Intense itching eyes face lip 11:15 Benadryl50 mg po  11:20 Itching spread to entire face/ ears / roof of mouth / sore throat / ear pain / eye pressure 11:40 symptoms decreased to mild 12:00 symptoms resolved 15:30sore throat tight/ ear pain returning/ eye pressure 15:45 Benadryl 50mg po 21:00 throat sore/ tight- eye pressure 21:30 Benadryl 50mg 1/28/21 1:11 tight cough /sore throat/ ear pain / itchy ears / scalp 1:11 Benadryl 50 mg po 7:00 rash on chest / sore throat/ tight throat/ itchy ears, face chest 8:30 Benadryl 50mg po 12:30 eye pressure/ ear pressure /ear pain/ sore throat / cough 12:40 Benadryl 50 mg po 17:00  eye pressure/ ear pressure /ear pain/ sore throat / cough 17:30 Benadryl 50 mg po 21:30  eye pressure/ ear pressure /ear pain/ sore throat / cough 21:30 Benadryl 50 mg po 1/29/21 Symptoms continue - Benadryl 50 mg po q4 hrs 1/30/21 Symptoms continue - Benadryl 50 mg po q4 hrs
The patient presents with 90 year old male presents after a fall. He was in his usual state of chronic illness when he was trying to get out of bed and he fell. It was an unwitnessed fall. Apparently fell onto his head and left side. He is unaware if he had any LOC or AMS. He only reports some discomfort to the right supraorbital region and left chestwall. He is not anticoagulated. Unable to provide more history secondary to dementia. He denies SOB or cough..     DISCHARGE SUMMARY HAS NOT BEEN UPLOADED AT THIS TIME.
About 2 weeks after last Vaccine I noticed that I had brain fog and disequilibrium.  I have a difficult time remembering a few minutes after obtaining a number then remembering when I want to write it down or after looking up the spelling of a word. I feel like I am on a cruise ship in slightly rough seas.  I walk like I am tipsy.  I do not have dizziness or nausea.
Discharge Provider: MD Primary Care Provider: PA Admission Date: 4/4/2023 Discharge Date: Apr 8, 2023  PRESENTING PROBLEM: AKI (acute kidney injury) (HCC)   HOSPITAL COURSE: Patient is a 72 y.o. male with past medical history significant for severe CAD s/p CABG and PCI, ischemic cardiomyopathy with combined systolic and diastolic heart failure s/p ICD in 2018, atrial fibrillation on anticoagulation, hypertension, lung cancer, CKD3, type 2 diabetes presents with complaints of increased dizziness with standing and generalized weakness.    Patient was admitted from March 16-17th after having ICD shocks that were occurring over a period of 3 weeks prior. Patient was then re-admitted to the hospital again from March 18-26th with AHRF due to CHF and COVID. His respiratory status improved with diuresis. He has an AKI that failed to improve and his creatinine remained around 2.5-2.9 throughout his admission. Nephrology at that time reported that his kidney function was likely a combination of cardiorenal syndrome and contrast nephropathy. They recommended further diuresis and started torsemide 20mg daily. He has been compliant with this since discharge. He attempted to contact cardiology for assistance who took prolonged time getting back to him and did not give him advice on fluid intake vs restriction. Ultimately contacted nephrology who recommended increased fluids, but given worsening symptoms, presented to the ER for evaluation.    Patient was evaluated by cardiology. They attributed his troponins to AKI and signed off without further input. Nephrology evaluated patient. His torsemide was held. He was given gentle IV fluids. He attempted to work with PT/OT and upon standing systolic BP dropped from 120 to 50's. Later worked with PT/OT and able to go home. As he gentle accumulated fluid, first with IV fluid help, then later only with removal of fluid restriction, his weight slowly increased, renal function drastically improved, and patient felt much improved. Nephrology graciously agreed to be the primary manager of his diuretics moving forward to help with patient's outpatient needs. As he improved he no longer had positive orthostatic vitals. He was discharged in stable condition on 4/8/23.
Arm pain a little numbness of arm. (I thought maybe hit a nerve when given the shot and it has to heal) Also had a Headache and was tired went home and slept.  Still having headaches 4 x times a week and my left arm/fingers sometimes is tingly like its asleep. Did that most of today. Still feeling tired.
pt recv vax 19JUN97 & w/in 48hr pt exp aching in the arm & a tingling sensation running down arm into hands;these sx still persist & appear irregularly;
saw two big , red areas , like two big spots , and are warm to touch; saw two big , red areas , like two big spots , and are warm to touch; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0131.20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On 29-Jan-2021, the patient experienced ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch). At the time of the report, TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Information has been received from a physician concerning a 34 month old male who on 26-JUL-2008 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck). On 02-JUN-2007, the patient developed a break through case of chickenpox. Unspecified medical attention was sought. The patient had 7 lesions and received no treatment. No further information was provided. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Immediately after H1N1 vaccine IM administration Pt reported not feeling well, could not breathe, obvious respiratory distress, weakness,and cyanosis, elevated heart rate epinephrine  auto injection given, 911 188/104 p.160, r 34,  Pt. able to speak no LOC noted, EMS  located very nearby, responded within approximately  5 minutes, Pt. was improving after epi, but when asked to sit upright by EMS unable to do so, became distressed again, Pt carried to stretcher by EMS, transported to Hospital via ambulance. 10/22/09 Medical record received for date 10/21/09 Lab value only:
After second dose on 10/14  I was completely fine until 10/17 around 5 pm I developed a really swollen throat and congestion outta nowhere. 10/18 -10/ 19 Congestion continued with sore throat only appearing at night. On 10/20 resting heart that's normally in 70's increased to high 80-90 that morning. Around 2pm on 10/20 it turned into tachycardia with heart rate bouncing between high 80s to around 120s. I rested thinking it would go away. On 10/21 I went to ER because tachycardia was so bad i began to experience shortness of breath. AS OF 10/22 I WAS STILL CONGESTED , SORE THROAT, WITH TACHYCARDIA ON DAY 8 AFTER MY SECOND SHOT
Patient was given the wrong injection. He was given Bexsero when he should have received Menveo. No adverse reactions.
Acute dyspnea, double vision, progressive muscle weakness leading to mechanical ventilation on 09/30/2009.  Suspect Guillain Barre syndrome vs Miller Fisher syndrome.  She is now on mechanical vent.  10/19/09 Hospital DC summary received service dates 9/30/09 to 10/11/09. Assessment: Acute polyneuropathy/Guillain-Barre Syndrome. Patient presents with hx of 5-10 days of progressive tightness (chest), double vision, confusion, shortness of breath. Respiratory arrest in radiology suite. Intubated, mechanical ventilation. Significant weakness of all extremities, unable to open eyes due to ptosis. IVIG. Plamapheresis. PEG tube. Abdominal Distension. Bowel sounds absent. Malnourished. Chills. Transferred to another facilty. 10/29/09:  Lab Results and Neurology notes received for dates of service 10/12/09 to 10/28/09. Dx:  Placid, areflexic quadriparesis with facial diplegia and opthalmoparesis, neuromuscular respiratory failure, s/p traheostomy and PEG Tube placement. Septic shock, ventilator associated pneumonia.  Ileus.  Large bilateral pleural effusion, anemia. Hypokalemia.  Assessment:  Movement of left wrist and right thigh.  Ciprofloxacin for UTI.  Plasma exchange. Febrile with temp up to 38.6.  Oxygen desaturation.   Tolerating tube feeds. Thorocentesis to drain pulmonary effusion.
This case was reported by a lawyer via a statement of injuries and described the occurrence of arthralgias in a male subject of unspecified age who was vaccinated with Lymerix for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix (unknown). At an unspecified time after vaccination with Lymerix, the subject experienced arthralgias, fatigue, mental fog, headaches, Bell's palsy, numbness, and tingling. He reportedly also suffered from rheumatologic, neurologic, and or cognitive impairment of an autoimmune, immune mediated, or other mechanism, all caused by vaccination with Lymerix. Additionally, he experienced decreased of daily life and decreased ability to participate in recreational activities. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the outcome of the events were unspecified.
no sx of fever, pain; put down for nap 930AM;mom in & out of room;found pt w/vomitus-unresponsive;CPR attempts unsuccessful @ hosp;no evidence of relation to vax;
After the COVID vaccine on my 2nd dose, a couple weeks almost 3 weeks later, I noted that there was spotting. Vaginal spotting. I thought something was wrong. It was 1-3 days. Suddenly it just kept spotting. We did diagnostics, a pelvic vaginal ultrasound, pap smear, everything. They gave me a medication to stop the spotting - Aygestin. We did a vaginal ultrasound. After another week, I started having more flow. Like having a menstrual period which is not normal for me because I was menopausal 10 years ago. I went to the doctor and did this all again. She said it was really heavy. I bled and bled. Because of the medication, it didn?t work. Doctor scheduled me for DNC which was May 13, 2021. She said I would expect less bleeding in 1-2 weeks. Then June 2021, I was still spotting so I kept taking this medication and didn?t seem like it was helping. I bled a lot after the surgery. My whole pants were bleeding, pool of blood coming from vagina. I was put on iron supplement for a month and checked and rechecked. Early July 2021 I went to the ER and the whole wheelchair had so much blood. I had a panic attack and BP was 290 over 150. They put me on new medication ? Norvasc 5mg 1xday, so it hasn?t been bad. Went and got another pap smear and said it was not cancer. I?m not the same, I?m very active at work and I?ve lost my focus. Kind of like when you wake up and your back hurts, confused sometimes.
WHEALS ON FACE AND EYES ITCHING. URTICARIA ON FACE.
After 1.5 weeks after receiving 3rd Moderna dose (booster), my scalp, head, and hands began to become itchy. The next day, my whole body began to itch. A single itch turned my skin red and irritated with raised marks and red bumps where I had itched. It would take around an hour for the irritated skin to calm down after a single itch. I was recommended to take two doses of Bennadrl daily to help. I don't believe it did much though I continued taking two doses daily for the next two weeks. My urge to itch has decreased but now I've been finding regions of redness (no hives) in splotches in random places around my body. Especially on my neck, chest and face.
Information has been received from a licensed practical nurse concerning a 52 year old male who on 13-MAR-2007 was vaccinated into the right deltoid muscle with a first dose of Pneumovax (Lot# 651406/0620F). Concomitant suspect therapy included tetanus toxoid, administered into the left deltoid. There was no illness at the time of vaccination. On 15-MAR-2007, the patient developed pain in the left deltoid at the injection site where the tetanus was administered. The nurse reported that the patient's pain radiated from the left deltoid up to the neck. The area was red and warm. It was also reported that the patient came to the clinic on 15-MAR-2007 complaining of a headache and stiff neck. The patient was reported as recovered on 15-MAR-2007. The nurse felt that the patient's experiences were important medical events. Additional information has been requested.
Within hours developed fever, dizziness, itchy and developed hives on legs and ankles, small amount on torso. Then developed trouble breathing and heart was racing. Client went to Urgent Care for evaluation. Was given epinephrine injection and a prescription. Was off work for 2 days.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse in the military concerning a 20-year-old female.  Neither medical history nor concomitant medications were reported.  On 26-Jan-2009, the patient received expired FLUMIST vaccine.  The vaccine had an expiration  date of 11-Jan-2009.  There was no adverse events associated with this medication error;  therefore, treatment and reported/sponsor causality assessments are not applicable, and the event is considered resolved.  Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that shortly after the product expired.  Additional information was received on 18-Mar-2009 indicated no adverse events were reported through the medical clinic.  Additional information was received on 12-May-2009 and incorporated into the narrative:  Product complaint investigation results.
This spontaneous report was received from a physician referring to a 19-month-old patient of unknown gender. Pertinent medical history or concurrent conditions were not reported. On 08-AUG-2017, the patient was vaccinated with improperly stored dose of VAQTA (lot # N005274, expiration date 03-APR-2018) (dosage information and route were not informed). Information regarding concomitant medication was not provided. Additionally, it was reported that the lowest temperature was 32°F and the higher was 54°F for 70 hours. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1709USA007325: US-009507513-1709USA012768.
Patient tested positive for covid few days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient tested positive for covid few days after receiving 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced COVID-19 (Patient tested positive for covid few days after receiving 1st dose). At the time of the report, COVID-19 (Patient tested positive for covid few days after receiving 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Coronavirus test: positive (Positive) reported on 15-Mar-2021 he tested positive last week for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment was reported for the event.
Patient had her 4th Moderna vaccine (bivalent) on 09-28-22 at Health Vaccine clinic. Patient was observed for 15 minute with no issues. Patient reports no issues with previous vaccines (previous vaccine received at another facility).  Approximately one hour after vaccine, patient was shopping and felt faint, lightheaded. No chest pain, slight fullness in neck. EMS was called, patient?s HR was 220, she was transported to hospital. Patient stated she had troponin elevations (initial Troponin HS 22, second draw 83 (reference ranges not reported). Patient was told she had a heart attack. No cardiac intervention was performed (cath or stents). Stated her heart rate came down to 100. No further information reported from hospital stay. She was discharged.  Patient saw her PCP on 10-03-22, EKG showed possible atrial enlargement. She stated her physician said the  hospital stay due to elevated HR, heart attack was not related to vaccine. Additional testing ordered  Patient stated she believes she had Covid in Apr 2020 (not confirmed by test) and has been seen at Covid Long haul clinic.
heart attack, ate dinner, rode bike on 16OCT95 p/vax; aching & diff sleeping noc of 16OCT95;sz on 17OCT95 to ER per ambulance
Inflamatory Response, swelling face, cold sore and genital herpes break out, fatigue